genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Tech Exclusives
Novel imPACT Isolation Technology Opens Doors to Improved Personalized Therapies
Bioprocessing
Newly Discovered Bacterial Natural Product Pathway Offers Potential for Synthetic Biology
Tech Exclusives
Dogs’ Cancer Genome May Aid Osteosarcoma in Kids
News
Charles River Labs to Open Second CRADL Facility in South San…
News
Zebrafish Screening Platform Boosts Spinal Cord Injury Drug Discovery
Insights
Insights
Gut Microbiome May Alter ALS Progression in Mice
Neuroscience
MS Looks to Transcriptomics for Answers on Neuronal Vulnerability
Insights
Top 10 Biopharma IPOs of January–June 2019
Tech Exclusives
A Toolbox for Keeping CRISPR in Check
Tech Exclusives
Drones Land in the Cell and Gene Therapy Space
A-Lists
Insights
Top 10 Biopharma IPOs of January–June 2019
Insights
Top 10 M&A Deals of January–June 2019
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Insights
Top 50 NIH-Funded Institutions of 2019
July 2019 Vol. 39 No. 7
25 Up-and-Coming Gene Therapies of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Insights
Gut Microbiome May Alter ALS Progression in Mice
Tech Exclusives
Novel imPACT Isolation Technology Opens Doors to Improved Personalized Therapies
Bioprocessing
Newly Discovered Bacterial Natural Product Pathway Offers Potential for Synthetic Biology
Tech Exclusives
Dogs’ Cancer Genome May Aid Osteosarcoma in Kids
Magazine
July 2019 Vol. 39 No. 7
CRISPR-Accelerated Gene Drives Pump the Brakes
July 2019 Vol. 39 No. 7
CRISPR Cinema: Scenes from the Cutting Edge
Tech Exclusives
Immunotherapy Targets Emerging Infectious Diseases
July 2019 Vol. 39 No. 7
Single-Cell Sequencing Sifts through Multiple Omics
Tech Exclusives
Bioreactor Design Adapts to Biopharma’s Changing Needs
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
GENcast: Precision Health’s Bloodline Starts with Great Science
GENcast
GENcast: A Biological GPS That Guides Awareness through Cellular Space
July 2019 Vol. 39 No. 7
Full-Length Transcript Sequencing—No Assembly Required
July 2019 Vol. 39 No. 7
Plasma Proteomics with NanoLC-MS
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Urological Disorders
Urological Disorders
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Urological Disorders
UPDATE: Endo Terminates Agreements with VIVUS, Acerus
Urological Disorders
Bard Acquiring Kobayashi’s Half-Share of Joint Venture
Urological Disorders
MDx Health Buys NovioGendix for Up to $8.8M
Urological Disorders
AltheRx Merging Into New Company to Advance Solabegron
Urological Disorders
Stem Cells Treated with Solifenacin Boost Myelin Production
Urological Disorders
Allergan Buys Rights to TARIS’ LiRIS for Up to $587.5M
Urological Disorders
Endo Unit Sells HealthTronics Laboratory Solutions to Metamark Genetics
Urological Disorders
Auxilium Snaps Up Urolology Therapeutics Firm Actient in $585M Deal
Urological Disorders
U.K. Clears Botox for Managing Urinary Incontinence
Urological Disorders
FDA Clears Astellas’ Myrbetriq for Overactive Bladder
Urological Disorders
Ezose, Hirosaki University Sign Glycomics Partnership to Identify Urologic Cancer Biomarkers
Urological Disorders
Salix Acquires Oceana Therapeutics for $300M
Urological Disorders
Astellas Reports Positive Data from Phase III Trial with Overactive Bladder...
Urological Disorders
Astellas to Submit Marketing Application for Overactive Bladder Therapy This Year...
Urological Disorders
Recordati Pays Nymox €10M Up Front for Rights to Late-Stage BPH...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
